The Company has agreed, on the terms and subject to the conditions set forth in the Purchase Agreement of even date herewith (the "Purchase -------- Agreement"), to issue and sell to each Purchaser shares (the "Preferred Shares") ---------...Registration Rights Agreement • December 29th, 1997 • White Rock Capital Management Lp • Patent owners & lessors • New York
1.1 Agreement to Purchase and Sell. Upon the terms and subject ------------------------------- to the conditions set forth herein, the Company agrees to sell at the Closing (as defined below), and each Purchaser agrees to purchase, the number of...Purchase Agreement • December 29th, 1997 • White Rock Capital Management Lp • Patent owners & lessors • New York
EXHIBIT BSubscription Agreement • January 23rd, 1998 • White Rock Capital Management Lp • Services-prepackaged software • Virginia
JOINT FILING AGREEMENTJoint Filing Agreement • August 14th, 2001 • White Rock Capital Management Lp • Services-telephone interconnect systems
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of SoftNet Systems, Inc., dated as of August 14, 2001, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
EXHIBIT A JOINT FILING AGREEMENTJoint Filing Agreement • January 3rd, 2000 • White Rock Capital Management Lp • Telephone & telegraph apparatus
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Osicom Technologies, Inc. dated as of January 3, 2000 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • January 31st, 2000 • White Rock Capital Management Lp • Services-telephone interconnect systems
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of SoftNet Systems, Inc. dated as of January 31, 2000 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • May 11th, 1998 • White Rock Capital Management Lp • Food and kindred products
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Hain Food Group, Inc. dated May 11, 1998 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • December 11th, 1997 • White Rock Capital Management Lp • Patent owners & lessors
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of IGEN International, Inc. dated December 11, 1997 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • July 7th, 1998 • White Rock Capital Management Lp • Retail-drug stores and proprietary stores
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Horizon Pharmacies, Inc. dated as of July 7, 1998 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • March 9th, 1998 • White Rock Capital Management Lp • Services-commercial physical & biological research
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Depomed, Inc. dated as of March 6, 1998 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • April 3rd, 1998 • White Rock Capital Management Lp • Steel works, blast furnaces & rolling & finishing mills
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Tyler Corporation dated as of April 3, 1998 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • April 20th, 1999 • White Rock Capital Management Lp • Converted paper & paperboard prods (no contaners/boxes)
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of ARTRA Group Incorporated dated as of April 20, 1999 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934.
Joint Filing AgreementJoint Filing Agreement • December 16th, 2020 • White Rock Capital Management Lp • Pharmaceutical preparations
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EXHIBIT A JOINT FILING AGREEMENTJoint Filing Agreement • November 28th, 2018 • White Rock Capital Management Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, par value $0.001 per share, of ZIOPHARM Oncology, Inc., dated as of November 27, 2018 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
